Cambrex Corporation acquires an Estonian pharmaceuticals and development company, AS ProSyntest
Advising Cambrex Corporation, a leading producer of pharmaceutical products listed on the New York Stock Exchange, in the acquisition of an Estonian pharmaceuticals and development company AS ProSyntest.






